193 related articles for article (PubMed ID: 24034143)
21. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).
Peris M; Espinàs JA; Muñoz L; Navarro M; Binefa G; Borràs JM;
J Med Screen; 2007; 14(2):81-6. PubMed ID: 17626707
[TBL] [Abstract][Full Text] [Related]
22. Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
Ibáñez-Sanz G; Milà N; Vidal C; Rocamora J; Moreno V; Sanz-Pamplona R; Garcia M;
PLoS One; 2021; 16(6):e0253369. PubMed ID: 34191813
[TBL] [Abstract][Full Text] [Related]
23. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancers detected through screening are associated with lower stages and improved survival.
Lindebjerg J; Osler M; Bisgaard C
Dan Med J; 2014 Jan; 61(1):A4758. PubMed ID: 24393588
[TBL] [Abstract][Full Text] [Related]
26. Analysis of colorectal cancer stage among HMO members targeted for screening.
Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
[TBL] [Abstract][Full Text] [Related]
27. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
[TBL] [Abstract][Full Text] [Related]
28. Does the location of screen-detected cancers differ from that seen in the unscreened population?
Harmston C; Hunter J; Wong L
Colorectal Dis; 2010 Apr; 12(4):324-6. PubMed ID: 19341402
[TBL] [Abstract][Full Text] [Related]
29. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
[TBL] [Abstract][Full Text] [Related]
30. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
31. [Results of the Czech National Colorectal Cancer screening programme - faecal occult blood tests].
Seifert B; Májek O; Zavoral M; Král N; Suchánek S; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():87-97. PubMed ID: 25494893
[TBL] [Abstract][Full Text] [Related]
32. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland.
Malila N; Palva T; Malminiemi O; Paimela H; Anttila A; Hakulinen T; Järvinen H; Kotisaari ML; Pikkarainen P; Rautalahti M; Sankila R; Vertio H; Hakama M
J Med Screen; 2011; 18(1):18-23. PubMed ID: 21536812
[TBL] [Abstract][Full Text] [Related]
33. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
Blanks RG; Benson VS; Alison R; Brown A; Reeves GK; Beral V; Patnick J; Green J
Br J Cancer; 2015 Apr; 112(9):1562-7. PubMed ID: 25742470
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching.
Leuraud K; Jezewski-Serra D; Viguier J; Salines E
Cancer Epidemiol; 2013 Dec; 37(6):959-67. PubMed ID: 24035240
[TBL] [Abstract][Full Text] [Related]
35. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
36. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
Webendörfer S; Riemann JF
Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
[TBL] [Abstract][Full Text] [Related]
37. Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy.
Mancini S; Ravaioli A; Falcini F; Giuliani O; Corradini R; De Girolamo G; Goldoni CA; Finarelli AC; Naldoni C; Landi P; Sassoli de Bianchi P; Bucchi L
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28032381
[TBL] [Abstract][Full Text] [Related]
38. Five-year experience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round.
Blom J; Kilpeläinen S; Hultcrantz R; Törnberg S
J Med Screen; 2014 Sep; 21(3):144-50. PubMed ID: 25070434
[TBL] [Abstract][Full Text] [Related]
39. Impact of faecal occult blood test screening on emergency admissions and short-term outcomes for colorectal cancer.
Libby G; Brewster DH; Steele RJ
Br J Surg; 2014 Nov; 101(12):1607-15. PubMed ID: 25219923
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
